ZIED TAWEH: Open Payments
NPI 1447282223 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 24 payments from 12 companies in 2025. Trend: 2023 $513 · 2024 $623 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| Exact Sciences Corporation | 2 | $44 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| REVANCE THERAPEUTICS, INC. | 1 | $24 |
| Intra-Sana Laboratories | 1 | $20 |
Products named: REXULTI, BREZTRI, Kerendia, QULIPTA, MOUNJARO, ZORYVE, GVOKE HYPOPEN, DAXXIFY.
Industry payments across CT — which companies pay providers there.
